webinar recording available

Rapid Deployment of Remote Trials During Containment

As health authorities worldwide struggle to contain the COVID-19 outbreak, there is a critical need to rapidly implement remote healthcare delivery capabilities.

In this 45 minute overview, our panel of experts will walk you through the recent changes made by health authorities worldwide to enable virtualization for remote care and ongoing studies.

What we will cover

Early lessons learned of a recent COVID-19 risk mitigation TeleVisit deployment
Getting virtualization technologies into patient and clinicians hands during community shutdowns
Overcoming challenges for rapid virtualization at a worldwide scale
Learn what the drivers towards digitizing the clinical trial process are

Watch now

Alison Holland

Head of Decentralized and Remote Trials, MEDABLE

Alison (Ali) Holland is Head of Virtual Trials at Medable and is chartered to design and expand the end-to-end capabilities needed to partially or fully virtualize clinical studies, building on the commitment to reduce clinical trial times by 50%. Ali has over 20 years of experience in a variety of leadership roles, including Feasibility Head and Six Sigma Black Belt at Covance, and Business Head and global General Manager at Roche/Genentech in one of their therapeutic area business groups. Having been engaged in over 300 studies across Biotechs, Pharma and all geographies, Ali brings an incomparable level of insight and technical excellence on the matter of operational needs for sites and patients.

moderator

arsalan arif

Founder & CEO, Endpoints News

Arsalan Arif is a news media entrepreneur who set out in 2015 to build his vision of an independent biotech news company at Endpoints News.